English| Français| Nederlands| INDEX| CONTACT 1 2 3 Stop About Us | R&D | Products | News | Responsibility | Careers Welcome Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Bristol-Myers Squibb International Visit our global website for more information on Bristol-Myers Squibb worldwide. Information June 2017 : European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for Previously Treated Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy May 2017 : European Commission Approves Bristol-Myers Squibb’s Opdivo (nivolumab) for Squamous Cell Cancer of the Head and Neck in Adults Progressing On or After Platinum-based Therapy Read more in our Press Releases in French & Dutch Our Mission To discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Read more about our mission Media and Press For any information about us, our activities and disease areas, email our Public Affairs team via pressinfo.belgium@bms.com Privacy Policy | Legal Notice | Pharmacovigilance | Contact This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact us on + 32/ 2.352.76.11 or e-mail: medicalinfo.belgium@bms.com ©2016 Bristol-Myers Squibb Belgium, Parc de l’Alliance, 4 Avenue de Finlande 1420 Braine l’Alleud. All company names and logos of BMS and / or the products of the company are trademarks of Bristol-Myers Squibb Company and / or affiliates, and are protected by national and international intellectual and industrial property laws. All rights to the contents of this website are reserved. Your use of this website is subject to the Legal Notice, the Privacy Policy, and the applicable laws and regulations.